Aurora Cannabis (TSE:ACB) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, September 22nd. Analysts expect the company to announce earnings of C($0.39) per share for the quarter.
Aurora Cannabis stock opened at C$8.62 on Monday. The company has a debt-to-equity ratio of 15.20, a current ratio of 3.17 and a quick ratio of 1.56. Aurora Cannabis has a one year low of C$7.50 and a one year high of C$84.24. The stock has a market capitalization of $970.35 million and a PE ratio of -0.58. The business’s fifty day moving average is C$12.26 and its 200 day moving average is C$10.31.
ACB has been the topic of several recent analyst reports. CIBC dropped their price objective on Aurora Cannabis from C$24.00 to C$20.00 in a research report on Tuesday, August 18th. Canaccord Genuity dropped their price objective on Aurora Cannabis from C$24.00 to C$21.00 in a research report on Wednesday, June 24th. Stifel Nicolaus dropped their price objective on Aurora Cannabis from C$16.00 to C$10.50 in a research report on Wednesday, September 9th. AltaCorp Capital raised their target price on Aurora Cannabis from C$2.50 to C$10.40 in a research report on Thursday, May 28th. Finally, ATB Capital raised their target price on Aurora Cannabis from C$10.40 to C$11.30 in a research report on Wednesday, September 9th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of C$12.18.
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Featured Story: Capital Gains
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.